COVID-19: Basics and Biosafety Precautions
Continuing Education Credits
Objectives
- Describe common characteristics of SARS-CoV-2, the virus that causes COVID-19.
- Summarize appropriate decontamination and waste handling procedures for COVID-19 specimens.
- Recognize appropriate biosafety precautions for handling COVID-19 specimens.
- Identify proper packaging and shipping requirements for COVID-19 specimens.
Course Outline
- Introduction
- Coronavirus (CoV) Overview
- Coronaviruses
- Coronavirus Naming Convention
- Coronavirus Appearance
- True or False: Coronaviruses cause disease in humans only.
- History, Symptoms, and Transmission
- COVID-19: Year One
- COVID-19 Symptoms
- COVID-19 Symptoms (continued)
- Asymptomatic and Pre-symptomatic
- COVID-19 Transmission
- Which of the following is not a recognized symptom of COVID-19?
- Specimens and Testing
- COVID-19 Specimens
- Emergency Use Authorization (EUA)
- COVID-19 Testing
- Laboratory Testing
- CLIA
- CDC recommends collecting and testing which of the following acceptable upper respiratory specimen types for initial diagnostic testing of SARS-CoV-2?
- Regulations, General Hazards, and Viability
- Regulations
- Regulations (continued)
- General Laboratory Hazards
- SARS-CoV-2 Viability
- Risk Mitigation
- Laboratory COVID-19 Safety
- Which of the following affect the viability of SARS-CoV-2?
- Cleaning, Disinfection, and Decontamination
- Cleaning and Disinfection
- Cleaning and Disinfection (continued)
- Disinfectants, Decontamination and Sterilization
- Disinfectants, Decontamination and Sterilization (continued)
- SARS-CoV-2 Decontamination
- Manufacturer Instructions for Disinfectant Use
- Disinfectant Preparation
- Antiseptic
- Laboratory COVID-19 Waste
- Spills
- True or False: Coronaviruses have a thick outer envelope wall, which makes them naturally resistant to many common disinfectants.
- True or False: Common laboratory disinfectants, such as diluted household bleach, work better as hand sanitizers than most commercially available alcohol-based antiseptic products.
- True or False: Laboratories must follow unique enhanced practices for handling COVID-19 infectious waste.
- Coronavirus Biosafety Precautions
- Risk Assessment
- Risk Assessments
- Risk Assessments (continued)
- True or False: A risk assessment is a process for evaluating the probability and consequences of exposure to a given hazard. The intent is to reduce the risk by establishing the appropriate hazard controls.
- Precautions and Biosafety
- Standard Precautions
- Standard Precautions (continued)
- Biological Safety Levels (BSLs)
- Biosafety
- Which biological safety level (BSL) does the CDC recommend COVID-19 specimens be handled and worked with?
- The EPA has a primary role for which responsibility?
- Engineering Controls and PPE
- Engineering Controls
- Biological Safety Cabinet (BSC)
- Administrative Controls
- Personal Protective Equipment (PPE)
- Respirators and Masks
- True or False: There are no significant differences between masks and respirators.
- Training
- Training
- In regards to COVID-19 training for employees, which of the following is true?
- Infectious Particles and Reducing the Spread
- Infectious Particles
- Infectious Particles (continued)
- Reducing the Spread of COVID-19
- Which federal agency plays a significant role for ensuring the safety of workers?
- To effectively inactivate SARS-Co-V-2, the virus that causes COVID-19, which list of disinfectants should a laboratory choose from?
- Shipping
- Shipping Training
- Shipping Requirements
- Shipping Laboratory Specimens
- Category B Shipments
- Category B Labeling and Marking
- Laboratories that need to send a COVID-19 sample out for referral testing must classify and ship the sample as:
- References
- References
